Champions Oncology (CSBR) Current Leases (2018 - 2026)

Champions Oncology's Current Leases history runs 9 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• In Q1 2026, Current Leases rose 6.62% year-over-year to $1.5 million; the TTM figure through Jan 2026 stood at $1.5 million (up 6.62% YoY), while the FY2025 annual figure was $1.5 million, up 10.02% from the prior year.
• Current Leases was $1.5 million for Q1 2026 at Champions Oncology, roughly flat from $1.5 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $1.5 million in Q1 2026 to a low of $1.0 million in Q1 2022.
• Historically, Current Leases has averaged $1.3 million across 5 years, with a median of $1.3 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Current Leases increased 28.69% in 2022, then grew 6.62% in 2026.
• A 5-year view of Current Leases shows it stood at $1.1 million in 2022, then climbed by 12.53% to $1.3 million in 2023, then advanced by 9.88% to $1.4 million in 2024, then rose by 8.85% to $1.5 million in 2025, then advanced by 0.26% to $1.5 million in 2026.
• The last three Current Leases figures came in at $1.5 million (Q1 2026), $1.5 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.